Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-545-9 | CAS number: 84-61-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://poisoncentres.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
Skin sensitization (LLNA:BrdU-ELISA method, mice) according to OECD 442b: the test item elicits a mild sensitisation response in mice following dermal exposure.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- from 11 May 2012 to 24 May 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442B (Skin Sensitization: Local Lymph Node Assay: BrdU-ELISA)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- other: CBA/JN
- Sex:
- female
- Details on test animals and environmental conditions:
- Species and strain :Mice, CBA/JN
Sex :Females (nulliparous and non-pregnant)
Age and weight range
(at order): 5 to 7 weeks old, 15 to 20 grams
Supplier : Charles River Italia S.p.A., Calco (Lecco), Italy.
Breeder : Charles River France Laboratories, Iffa Credo, Domaine des Oncins B.P. 0109, F 69592 L’ARBRESLE CEDEX, France.
Date of arrival : 12 April 2012
Weight range at arrival : 15.5 to 17.7 grams
Acclimatisation period : At least 5 days
Veterinary health check : After arrival
Caging:
No. of animals/cage: 1/cage during the study; up to 5 during acclimatisation
Housing: Polysulphone solid bottomed cages measuring 35.5 x 23.5 x 19 cm with nesting material
Cage tray control: Daily inspected and changed as necessary (at least twice/week)
Water and diet:
Water : Drinking water supplied to each cage via a water bottle
Water supply : Ad libitum
Diet : 4 RF 21 (Mucedola S.r.l., Via G. Galilei, 4, 20019, Settimo Milanese (MI) Italy)
Diet supply : Ad libitum throughout the study
Records of analyses of water and diet are kept on file at RTC. Components present in the drinking water or diet are not at a level likely to interfere with the purpose or conduct of the study.
Housing conditions (parameters set):
Room lighting : Artificial (fluorescent tubes), daily light/dark cycle of 12/12 hours
Air changes : Approximately 15 to 20 air changes per hour
Temperature range : 22°C ± 2°C
Relative humidity range : 55% ± 15%
Actual conditions were monitored and recorded and records retained. No relevant deviations occurred. - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- Preliminary phase:
25, 10, 5, 2.5, 1% w/w in acetone:olive oil 4:1 (v/v)
No toxicity signs (clinical signs or toxicologically relevant body weight losses) were observed at any concentration tested.
According to the results of the irritation screening, the concentration judged as minimally irritant was 10% w/w.
Main assay:
In the main assay, the test item was topically administrered at the concentrations of 10, 5 and 2.5% w/w, in acetone:olive oil 4:1 (v/v). - No. of animals per dose:
- group of 7 animals for each concentration.
- Details on study design:
- A preliminary irritancy test was carried out to select three concentrations to be used in a main assay, according to the criteria described in the relevant guideline for this test.
A main phase was then carried out to fully evaluate lymph node cell reaction.
Main test:
Treatment schedule of animals is summarised as follows.
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6
D D D - BrdU C
D : Dermal application of test item, positive control or vehicle(s) 25 µL/ear (50 µL/animal)
BrdU : Intraperitoneal administration of BrdU
C : Sacrifice, processing of lymph nodes and determination of Cell Proliferation
Dosing with the test or control items
Frequency of treatment : Three consecutive days (Days 1, 2, 3) with the test or control item formulations.
Dose calculation : Dose volume of 25 µL/ear/day (50 µL/animal/day) for each animal.
Dosing method : Topical application of the formulations to the dorsal surface of each ear, using a Gilson micropipette.
Dosing with 5-Bromo-2-deoxyuridine (BrdU)
Frequency of treatment : Once only, on Day 5.
Dose calculation : A solution of BrdU, at a concentration of 10 mg/mL in physiological saline (NaCl 0.9%) was administered at the dose volume of 0.5 mL/animal.
Dosing method : Intraperitoneal injection, using 25 G needle and a plastic graded syringe of a suitable volume.
In life observations
Mortality and morbidity: Twice daily.
Clinical signs : Before dosing commenced and daily up to sacrifice (approximately 1 hour after each dosing, in the days of treatment).
Body weight : Allocation (Day 1) and sacrifice (Day 6).
Terminal studies
Termination : Day 6, approximately 24 hours after BrdU injection.
Euthanasia method: Carbon dioxide narcosis.
The test item is considered to induce sensitisation when the SI (stimulation index) for any single treatment dose group is greater or equal to1.6.
It is not required that an increased response is observed at increasing dose levels, but dose-related activity and/or statistical significance may be taken as further evidence of a sensitisation effect (i.e. in case of borderline results with 1.6 ≤ SI ≤ 1.9). - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Statistical analysis:
Differences between each treated group and the control group (individual BrdU labelling indices) were assessed by Dunnett's test. The homogeneity of the data was verified by Bartlett's test before Dunnett's test. If data were found to be inhomogeneous a Modified t test (Cochran and Cox) was applied. - Positive control results:
- In the group treated with the positive control item, a stimulation index of 6.97 was calculated. As it was greater than 2, the test system was regarded as valid.
- Parameter:
- SI
- Value:
- 1.8
- Test group / Remarks:
- low dose group
- Parameter:
- SI
- Value:
- 1.91
- Test group / Remarks:
- mid dose group
- Parameter:
- SI
- Value:
- 1.24
- Test group / Remarks:
- high dose groups
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: not applicable
- Cellular proliferation data / Observations:
- In a first experiment the calculated stimulation indices were 1.80, 1.91 and 1.24 respectively at low, mid and high dose groups. Since these results were considered borderline, a second experiment was repeated to confirm them. In the second experiment, increases in cell proliferation of draining lymph nodes were observed in all test item treated groups being the calculated stimulation index equal to 2.22, 2.82 and 1.94 respectively at low, mid and high dose level. The proliferative responses at all dose levels were higher than the threshold value of 1.9 for clear positive result. In this experiment, the observed increases were statistically significant at the low and mid- dose level (Groups 2 and 3) but not in the high dose level (Group 4). No dose response relationship was observed.
- Interpretation of results:
- other: sensitising
- Conclusions:
- The potential of the test item, DICYCLOHEXYLPHTHALATE, to cause skin sensitisation reactions following topical application to the skin of CBA/JN (CBA/J) mice, was assessed using the LLNA:BrdU-ELISA method, according to the OECD Guideline for testing of chemicals no. 442b.
In the main sensitisation assay, the test item was administered at the concentrations of 10, 5 and 2.5% w/w.
Increases in cell proliferation were observed in all test item treated groups being the calculated stimulation index equal to 2.22, 2.82 and 1.94 respectively in low, mid- and high dose level.
The stimulation index (SI) values at the three dose levels were higher than the threshold of 1.9 for a clear positive results, established in the relevant guideline. Therefore, the results obtained in this study indicate that the test item elicits a mild sensitisation response in mice following dermal exposure. - Executive summary:
The potential of the test item, DICYCLOHEXYLPHTHALATE, to cause skin sensitisation reactions following topical application to the skin of CBA/JN(CBA/J) mice, was assessed using the LLNA:BrdU-ELISA method, according to the OECD Guideline for testing of chemicals no. 442b.
Preliminary phase
Five concentrations (25, 10, 5, 2.5, 1% w/w in acetone:olive oil 4:1 (v/v), the highest being selected on the basis of a preliminary solubility test) were selected to be used in the preliminary phase, to identify a non toxic and minimally irritant concentration in order to avoid false positive results.
No toxicity signs (clinical signs or toxicologically relevant body weight losses) were observed at any concentration tested. According to the results of the irritation screening, the concentration judged as minimally irritant was 10% w/w.
Main assay
In the main assay, the test item was topically administrered at the concentrations of 10, 5 and 2.5% w/w, in acetone:olive oil 4:1 (v/v).No mortality or toxicologically relevant clinical signs were recorded in animals treated at all dose levels. Changes in body weight observed during the study were within the expected range for this strain and age of animals.
Increases in cell proliferation of draining lymph nodes were observed in the three test item treated groups. The calculated stimulation indices were equal to 2.22, 2.82 and 1.94 respectively at low, mid- and high dose level.
The variations were statistically significant at the low and mid- dose levels but not at the high dose level.
No dose response relationship was observed.
The stimulation index (SI) values at the three concentrations were slightly over the threshold of 1.9 for a positive result as established in the relevant guideline. Therefore, the results obtained in this study indicate that the test item
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
The potential of the test item, DICYCLOHEXYLPHTHALATE, to cause skin sensitisation reactions following topical application to the skin of CBA/JN(CBA/J) mice, was assessed using the LLNA:BrdU-ELISA method, according to the OECD Guideline for testing of chemicals no. 442b. The results obtained in this study indicate that the test item elicits a mild sensitisation response in mice following dermal exposure.
Justification for selection of skin sensitisation endpoint:
GLP study in compliance with international recognized guidelines.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
According to the European Directives (Council Regulation (EC) No. 1272/2008 and subsequent revisions) the substance is classified as skin sensitizer (Category I).
No information is available for respiratory sensitization, thus the notifiable is not classified as a respiratory sensitizer as data are lacking
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)